Home
Conditions
Lymphoma, Extranodal NK-T-Cell

Clinical trial condition

Lymphoma, Extranodal NK-T-Cell

Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.

157 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Extranodal NK-T-Cell trial results

Completed

Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas

NCT01445535

Conditions: Gamma Delta Hepatosplenic T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients

NCT03079544

Conditions: Extranodal NK-T-Cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Lymphoma House086 Beijing, Beijing Municipality, China

Xinhua Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

NCT02733458

Conditions: Extranodal NK-T-Cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Shanghai Dong Fang hospital Shanghai, Shanghai Municipality, China

Department of Hematology, Renji Hospital Shanghai, Shanghai Municipality, China

South Renji hospital Shanghai, Shanghai Municipality, China

Xin Jiang People's Hospital Ürümqi, Xinjiang, China

View Trial Details

Completed

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

NCT00424242

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +112 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00536601

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +137 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT00612716

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma

NCT01258998

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +82 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

NCT01075321

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +59 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

NCT02764281

Conditions: Extranodal NK-T-Cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China

Shanghai Eye Ear Nose and Throat Hospital, Fudan University Shanghai, Shanghai Municipality, China

Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

Xinhua Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Lymphoma, Extranodal NK-T-Cell

Lymphoma, Extranodal NK-T-Cell trial results

Related conditions